Balyasny Asset Management’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-110,491
Closed -$417K 3154
2025
Q2
$417K Sell
110,491
-37,649
-25% -$148K ﹤0.01% 2360
2025
Q1
$671K Buy
+148,140
New +$784K ﹤0.01% 2167
2024
Q3
Sell
-25,858
Closed -$165K 2931
2024
Q2
$165K Buy
+25,858
New +$166K ﹤0.01% 2363
2024
Q1
Sell
-279,978
Closed -$2.59M 2823
2023
Q4
$2.59M Sell
279,978
-220,034
-44% -$1.8M 0.01% 1371
2023
Q3
$5.06M Buy
500,012
+82,024
+20% +$979K 0.01% 1103
2023
Q2
$5.22M Sell
417,988
-633,978
-60% -$7.55M 0.01% 1035
2023
Q1
$12.3M Sell
1,051,966
-603,980
-36% -$7.7M 0.04% 703
2022
Q4
$17.6M Buy
1,655,946
+516,367
+45% +$4.99M 0.06% 535
2022
Q3
$11.1M Buy
1,139,579
+189,654
+20% +$2.51M 0.04% 643
2022
Q2
$13.8M Buy
+949,925
New +$16.2M 0.06% 541
2022
Q1
Sell
-150,005
Closed -$5.94M 2653
2021
Q4
$5.94M Buy
+150,005
New +$6.84M 0.03% 796
2020
Q4
Sell
-11,982
Closed -$439K 1515
2020
Q3
$439K Buy
+11,982
New +$407K ﹤0.01% 1126
2019
Q4
Sell
-20,611
Closed -$652K 1308
2019
Q3
$652K Buy
+20,611
New +$811K ﹤0.01% 906

Other funds holding HCAT